Merit Medical Systems

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MMSI and other ETFs, options, and stocks.

About MMSI

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. 

CEO
Martha Goldberg Aronson
CEOMartha Goldberg Aronson
Employees
7,400
Employees7,400
Headquarters
South Jordan, Utah
HeadquartersSouth Jordan, Utah
Founded
1987
Founded1987
Employees
7,400
Employees7,400

MMSI Key Statistics

Market cap
5.30B
Market cap5.30B
Price-Earnings ratio
45.75
Price-Earnings ratio45.75
Dividend yield
Dividend yield
Average volume
782.95K
Average volume782.95K
High today
$89.94
High today$89.94
Low today
$88.27
Low today$88.27
Open price
$88.27
Open price$88.27
Volume
430.23K
Volume430.23K
52 Week high
$111.45
52 Week high$111.45
52 Week low
$78.12
52 Week low$78.12

Stock Snapshot

With a market cap of 5.3B, Merit Medical Systems(MMSI) trades at $89.39. The stock has a price-to-earnings ratio of 45.75.

As of 2025-11-12, Merit Medical Systems(MMSI) stock has fluctuated between $88.27 and $89.94. The current price stands at $89.39, placing the stock +1.3% above today's low and -0.6% off the high.

The Merit Medical Systems(MMSI)'s current trading volume is 430.23K, compared to an average daily volume of 782.95K.

In the last year, Merit Medical Systems(MMSI) shares hit a 52-week high of $111.45 and a 52-week low of $78.12.

In the last year, Merit Medical Systems(MMSI) shares hit a 52-week high of $111.45 and a 52-week low of $78.12.

MMSI News

Simply Wall St 2d
Did Positive WAVE Trial Results and Global Approvals Just Shift Merit Medical Systems' Investment Narrative?

In early November 2025, Merit Medical Systems announced positive 24-month clinical results from the WAVE trial for its WRAPSODY Cell-Impermeable Endoprosthesis,...

Did Positive WAVE Trial Results and Global Approvals Just Shift Merit Medical Systems' Investment Narrative?
Simply Wall St 4d
Merit Medical Systems: Valuation in Focus After Positive WAVE Trial Data on WRAPSODY Endoprosthesis

Merit Medical Systems (MMSI) saw attention after unveiling positive 24-month results from the WAVE trial for its WRAPSODY Cell-Impermeable Endoprosthesis. The d...

Merit Medical Systems: Valuation in Focus After Positive WAVE Trial Data on WRAPSODY Endoprosthesis

Analyst ratings

91%

of 11 ratings
Buy
90.9%
Hold
9.1%
Sell
0%

People also own

Based on the portfolios of people who own MMSI. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.